Alex Zhavoronkov is the founder of Insilico Medicine. Insilico Medicine has raised $416M in total funding. Latest round: Series E.
Alex Zhavoronkov is the founder and CEO of Insilico Medicine, an AI-driven biotechnology company he established in 2014. He has led the company through major funding rounds and a public listing, overseeing its entry into clinical trials for an AI-designed cancer drug and the launch of its Nach01 chemistry foundation model.
Full founder directory · Investor directory · Company funding database · Fundraising library